Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| The awareness has been enhanced due to principal factors the following positive results from the CCL study of clinical data that was presented by Ethos |
| Also, the combination of data, KOLs speaking positively about our product and allowing vet acceptance of Spryng in dogs and cats with the following events that have been happening |
| We have recently witnessed a strong movement of positive awareness by small animal veterinary doctors of our product Spryng |
| Our first one of the year in terms of multiple -- trade shows was the veterinary medical expo in Orlando mid-January where we had five veterinary doctors that were speakers mentioning the Spryng product, which was a very nice surprise that drew very good attendance and audience into our booth |
| This year, they were familiar with it and new vets that were using it and hearing really good things about and wanted to learn more and we were able to convert a lot of those into orders |
| That's a very powerful way of really getting the word out to the small animal doctors |
| Finally, we plan to increase our social media focus by highlighting our clinical study results and positive outcomes from the use of Spryng |
| And then this evening at VOS, Veterinary Orthopedic Societies Conference on HEPS, we expect to see another very good type presentation by the clinician |
| The final results of the cranial cruciate disease study provided by Ethos indicated significant improvement in 39 dogs injected with Spryng |
| It is our position that this clinical trial demonstrates that Spryng is a reasonable non-invasive alternative for patients with cranio crucial ligament disease when patients and/or owner factors preclude surgical intervention |
| She is a professor at Washington State University Veterinary School, and she basically did a pure review article in the today's veterinary practice July issue of 2023, which she indicated that Spryng should be looked at its first use product, as well as also a good choice as an alternative for dogs that cannot take NSAT, which is about 5% of the population in the United States out of the 83 million dogs |
| Such a library will assist our sales team to gain veterinarian acceptance this Spryng |
| The favorable results found in this first cohort of dogs of this study will be presented at the Veterinary Orthopedic Society Conference today on February 12, 2024 |
| The acquisition of clinical data proving the safety and efficacy of Spryng in a multitude of indications is incredibly important to PetVivo |
| Again, thank you for joining our call today. |
| So that gives us the top two distributors, which gives a lot of confirmation of what they see this product potential is as we move forward |
| Bob Folkes Thank you, John, and good afternoon, everyone |
| Statement |
|---|
Please consider a small donation if you think this website provides you with relevant information